About
Our research within the Economics of Genomics and Precision Medicine Unit (EiGEN) aims to provide health economics evidence to support cost-effective and value-based implementation of genomics and precision medicine in Australia.
In partnership with policy makers, community, industry and clinical experts, we strive to ensure a sustainable future for genomic medicine and advance the methodological frontiers of our discipline.